These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 4006379

  • 21. Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects.
    Osman MA, Patel RB, Irwin DS, Welling PG.
    Biopharm Drug Dispos; 1983; 4(1):63-72. PubMed ID: 6839003
    [Abstract] [Full Text] [Related]

  • 22. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA, Straughan AB.
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [Abstract] [Full Text] [Related]

  • 23. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
    Rojanasthien N, Kovjiriyapan K, Manorot M, Pothirat C.
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of whole and half Theo-Dur tablets.
    Fagerström PO.
    Eur J Respir Dis Suppl; 1980 Jun; 109():62-6. PubMed ID: 6934089
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA, Kisicki J, Straughn AB.
    Clin Ther; 1994 Jun; 16(4):686-92. PubMed ID: 7982257
    [Abstract] [Full Text] [Related]

  • 26. Update on the pharmacodynamics and pharmacokinetics of theophylline.
    Hendeles L, Massanari M, Weinberger M.
    Chest; 1985 Aug; 88(2 Suppl):103S-111S. PubMed ID: 3893922
    [Abstract] [Full Text] [Related]

  • 27. Effects of food on the absorption of theophylline in children.
    Pedersen S.
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):704-9. PubMed ID: 3771960
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation.
    Hussein Z, Friedman M.
    Pharm Res; 1990 Nov; 7(11):1167-71. PubMed ID: 2293217
    [Abstract] [Full Text] [Related]

  • 30. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans.
    Raz I, Bialer M, Salame K, Bar-On H.
    Eur J Clin Pharmacol; 1984 Nov; 26(3):401-3. PubMed ID: 6734702
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet.
    Lagas M, Jonkman JH.
    Eur J Clin Pharmacol; 1983 Nov; 24(6):761-7. PubMed ID: 6884413
    [Abstract] [Full Text] [Related]

  • 34. Food interactions with sustained-release theophylline preparations. A review.
    Jonkman JH.
    Clin Pharmacokinet; 1989 Mar; 16(3):162-79. PubMed ID: 2656048
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Bioavailability of a new sustained-release theophylline capsule in fasted and non-fasted healthy subjects: single and multiple dosing studies.
    West RJ, Boehm G, Dwyer M, Williams DB, Sansom LN, Penna AC.
    Biopharm Drug Dispos; 1990 Mar; 11(2):165-77. PubMed ID: 2328301
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.